Monitoring progress regularly is critical
Combination therapy using both peptides represents an advanced approach that some physicians recommend for complex cases
During freeze-drying, the peptides are gently frozen and placed under low pressure so the water turns straight from ice into vapor
Protocol approach 2: gut-focused autoimmune support (BPC-157 plus KPV) Goal: Restore gut barrier integrity and reduce intestinal inflammation Components: BPC-157 : 200-300 mcg twice daily, orally or subcutaneously near the abdomen (promotes mucosal healing, angiogenesis) KPV: 200-500 mcg daily, orally (NF-kB inhibition, cytokine reduction, PepT1-mediated gut absorption) Rationale: For autoimmune conditions with significant gastrointestinal involvement, including IBD, celiac-associated inflammation, or any autoimmune condition complicated by leaky gut, this combination addresses both the physical barrier damage (BPC-157) and the inflammatory signaling (KPV)
It protects organs by shielding cells from damage and aids inflammation reduction
Once opened, it should generally be used immediately because it does not have the same protection against bacterial growth
